Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000693406 | SCV000821274 | pathogenic | Actin accumulation myopathy | 2023-10-13 | criteria provided, single submitter | clinical testing | This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 6 of the ACTA1 protein (p.Glu6Lys). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with congenital fiber type disproportion, congenital myopathy, and/or nemaline myopathy (PMID: 19562689, 24642510, 26172852). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 42107). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ACTA1 protein function. For these reasons, this variant has been classified as Pathogenic. |
Centre for Mendelian Genomics, |
RCV001198948 | SCV001369943 | likely pathogenic | Progressive scapulohumeroperoneal distal myopathy | 2019-08-01 | criteria provided, single submitter | clinical testing | This variant was classified as: Likely pathogenic. The following ACMG criteria were applied in classifying this variant: PM2,PP2,PP3,PP4,PP5. |
Gene |
RCV000034934 | SCV000058542 | not provided | Congenital myopathy with fiber type disproportion | no assertion provided | literature only |